In- VitroAntimycobacterial Activity of New Synthetic Amidrazone Derivatives
- 1 June 1993
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 5 (3) , 164-167
- https://doi.org/10.1080/1120009x.1993.11739227
Abstract
After preliminary in vitro screening of 15 newly synthesized compounds belonging to the chemical class of N1-(aryliden)-4-pyridinecarboxyamidrazoncs against Mycobacterium tuberculosis reference strain H37 Rv, we determined the minimum inhibitory concentrations (MICs) of the six most promising chemicals against different species of Mycobacterium and different strains of M. tuberculosis. The agar dilution method was employed against M. gordonae, M. bovis, M. kansasi, M. avium, M. fortuitum and on eighteen different strains of M. tuberculosis, isolated from human bronchial aspirates. The results obtained confirmed that the newly synthesized chemicals possessed a very interesting antitubercular activity, their MICs ranging from 4 μg/ml to 16 μg/ml.Keywords
This publication has 2 references indexed in Scilit:
- Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infectionAntimicrobial Agents and Chemotherapy, 1991
- Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to Various Antibacterial DrugsMicrobiology and Immunology, 1989